arrow_back Back Filing freshness 20-F Q4 FY2025 SEC EDGAR
download Export Data

CollPlant Biotechnologies Ltd

CLGN
$0.33 ▲ +0.03 (+11.26%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
9 Visible periods
7 Metrics
Peer-ranked Benchmarks
Price Chart
10
Health
Poor
Bearish
auto_awesome

Analytical Summary

CollPlant Biotechnologies Ltd faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —
Dividend Yield —
Revenue Growth —
Op. Margin —
ROIC —
FCF / Share —
Trailing P/E —
Price / Book 0.7x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Aug 7, 2026.

9-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Long-Term Debt Long-term obligations
$30.00K
↑ +172.7% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓
0
Returns
3
Cash Quality ↓
55

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 9 years · 9 quarters